Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models
2017 ◽
Vol 174
(9)
◽
pp. 822-835
◽
Michael P Johnson
◽
Mark A Muhlhauser
◽
Eric S Nisenbaum
◽
Rosa M A Simmons
◽
Beth M Forster
◽
...
M Kellner
◽
C Muhtz
◽
K Stark
◽
A Yassouridis
◽
K Wiedemann
1995 ◽
Vol 5
(3)
◽
pp. 223-228
◽
S. Richard Baker
◽
John Goldsworthy
◽
Raymond C. Harden
◽
Craig R. Salhoff
◽
Darryle D. Schoepp
1994 ◽
Vol 256
(1)
◽
pp. 109-112
◽
Valeria Bruno
◽
Agata Copani
◽
Giuseppe Battaglia
◽
Rocco Raffaele
◽
Huruiko Shinozaki
◽
...
1999 ◽
Vol 273
(3)
◽
pp. 191-194
◽
Ann Bond
◽
Nella Ragumoorthy
◽
James A. Monn
◽
Caroline A. Hicks
◽
Mark A. Ward
◽
...
2017 ◽
Vol 45
(7)
◽
pp. 912-921
◽
Thomas Boerner
◽
Alexei M. Bygrave
◽
Jingkai Chen
◽
Anushka Fernando
◽
Stephanie Jackson
◽
...
1995 ◽
Vol 689
(2)
◽
pp. 281-288
◽
Hiroyuki Gotani
◽
Miyuki Kuno
◽
Fusao Nakamura
◽
Shiushi Matsuura
1998 ◽
Vol 281
(5381)
◽
pp. 1349-1352
◽
1996 ◽
Vol 207
(1)
◽
pp. 70-72
◽
Masatoshi Yoshino
◽
Satsuki Sawada
◽
Chosaburo Yamamoto
◽
Haruyuki Kamiya
2016 ◽
Vol 45
(2)
◽
pp. 137-144
◽
Y. Anne Pak
◽
Amanda J. Long
◽
William F. Annes
◽
Jennifer W. Witcher
◽
Mary Pat Knadler
◽
...